Revised forecast
Fiscal year ending March 2027 · Full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
The company expects further earnings growth through increasing the added value of health big data utilization services and expanding the range of data types, as well as enhancing the quality and improving the operational efficiency of its remote imaging diagnosis support services, while continuing upfront investment for future growth.
| Item | Details |
|---|---|
| Net Sales | Not disclosed → ¥60,500 million（+19.9%） |
| Operating profit | Not disclosed → ¥11,500 million（+9.3%） |
| Profit attributable to owners of the parent | Not disclosed → ¥7,100 million（+4.9%） |
| Net income per share | Not disclosed → 108.19 yen and sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Previous-period results | Revenue ¥50,462 million, operating profit ¥10,521 million, profit before tax ¥9,964 million, profit for the year attributable to owners of the parent ¥6,765 million, basic earnings per share ¥103.44 |
| Reason for the revision | The company expects further earnings growth through increasing the added value of health big data utilization services and expanding the range of data types, as well as enhancing the quality and improving the operational efficiency of its remote imaging diagnosis support services, while continuing upfront investment for future growth. |
| Dividend forecast revision | The year-end dividend for the fiscal year ended March 2026 has been set at ¥18 per share, from the previously undetermined amount. The dividend forecast for the fiscal year ending March 2027 remains undetermined. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the health big data business, the number of clients, including health insurance societies, and annual transaction value increased, as did the number of IDs issued for Pep Up. In telemedicine, the number of participating medical institutions increased. For the next fiscal year, the company plans to increase the added value of its data utilization services, expand the range of data types, enhance service quality and improve operational efficiency, while continuing upfront investment for future growth.